Intelligence · Clinical Pipeline
Vertex Pharmaceuticals (Australia) Pipeline
All ClinicalTrials.gov programs at Vertex Pharmaceuticals (Australia) — phase, modality, and trial IDs.
- Programs
- 61
Quick answer
Vertex Pharmaceuticals (Australia) has 61 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
VX-765
Vertex Pharmaceuticals (Australia) Pty.
Psoriasis
1 trial -
VX-765 Part A
Vertex Pharmaceuticals (Australia) Pty.
Epilepsy
1 trial -
VX-770
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
3 trials -
VX-787
Vertex Pharmaceuticals (Australia) Pty.
Influenza Virus
1 trial -
VX-814
Vertex Pharmaceuticals (Australia) Pty.
Alpha 1-Antitrypsin Deficiency
1 trial -
VX-864
Vertex Pharmaceuticals (Australia) Pty.
Alpha1-Antitrypsin Deficiency
1 trial -
VX-864
Vertex Pharmaceuticals (Australia) Pty.
Alpha-1 Antitrypsin Deficiency
1 trial -
VX-950
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
2 trials -
VX-993
Vertex Pharmaceuticals (Australia) Pty.
Diabetic Peripheral Neuropathic Pain
1 trial -
VX-993
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
1 trial -
biricodar dicitrate
Vertex Pharmaceuticals (Australia) Pty.
Lung Cancer
1 trial -
telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C Virus Infection
1 trial -
telaprevir or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial
Frequently asked questions
How many pipeline programs does Vertex Pharmaceuticals (Australia) have?
61 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs